C07F9/5435

Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug

The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. Methods of enhancing an anti-tumor immune response by administering mito-ATO are further provided.